ipamorelin clinical trial healthy volunteers Discovery Why Do Clinical Trials Need

Preventing Alzheimers disease-related gray matter atrophy by B-vitamin treatment

Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)

While our study provides valuable insights, several limitations should be acknowledged: (1) The current investigation did not elucidate the molecular mechanisms underlying the protective effects of HRW against HE

Horm Res 51(3):128134 Vijayan A, Franklin SC, Behrend T, Hammerman MR, Miller S (1999) Insulin-like growth factor I improves renal function in patients with end-stage chronic renal failure

Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin